News

The finding should help to light the way for development of new treatments against botulism, a paralytic illness caused by the toxin. As small amounts of botox are

In contrast to current treatments that contain insecticides such as lindane, malathion, permethrin and pyrethrins that are neurotoxic to insects, Piedmont’s patented treatment utilizes an insecticide-free, non-neurotoxic formulation.

The company expects to have the capacity to produce up to 400 million treatments annually by the end of 2006 – an addition of 100 million treatments. Tamiflu

Under the agreement, Daiichi Sankyo has committed to start one therapeutic antibody program with MorphoSys and will receive an option for further programs. During the initial two-years, Daiichi

Aricept is already approved in the US, Japan and the EU for the treatment of mild to moderate Alzheimer’s disease. Eisai, which markets the drug with its partner

The collaboration is designed to combine the preclinical biology skills and clinical expertise resident at Columbia and Bologna, with translational and drug development competencies of Edison, with the

The research also suggests that some of these miRNAs, when acting abnormally, may contribute to certain forms of leukemia. “Basically, we found that a specific set of miRNA

Increasing international travel, trafficking in wildlife, political instability, and terrorism have made emerging infectious diseases a global concern. Viral hemorrhagic fevers (VHF) are of specific concern because they

Under the terms of the agreement, BioMarin will receive payments and royalties based on the product’s approval, launch and level of sales. BioMarin will retain commercial rights outside